Petwealth's New Platform Moves Pet Health from the Clinic to the Cloud

MIAMI, FL – August 07, 2026 – The future of pet health may not be found in a waiting room, but in a small collection kit delivered to your door. At the SuperZoo 2026 trade show in Las Vegas, Petwealth, a diagnostics and intelligence company, unveiled the next evolution of its platform, signaling a significant shift in how we monitor the well-being of our animal companions. The modernized service combines at-home, clinical-grade testing with an integrated network of veterinary support, aiming to make proactive health screening a simple, accessible part of modern pet ownership.

Founded in 2025 after CEO Angelo Palivos lost his own dog to an illness he believes could have been caught sooner, Petwealth is built on a principle of early detection. “Petwealth has evolved tremendously since we introduced the company,” Palivos stated. “We listened to veterinarians, pet parents and industry partners to build an experience that reflects what modern pet care should look like: accessible, intuitive and connected.” This launch isn't just a product update; it's an ambitious bid to rewire the pet care industry from a reactive, appointment-based system to a proactive, data-driven ecosystem.

A New Era of Empowered Pet Parents

For decades, the standard model of pet care has been largely reactive, with visits to the veterinarian often prompted by visible signs of distress. Petwealth aims to upend this paradigm by providing pet parents with the tools to look 'under the hood' before problems become apparent. The company offers a suite of at-home testing kits for dogs and cats covering oral, respiratory, and fecal health, screening for over 100 different biomarkers.

At the core of the offering is a streamlined process: a pet parent collects a sample using a non-invasive kit, sends it to Petwealth’s in-house molecular diagnostics lab in Texas, and receives a comprehensive report within 24 to 48 hours of receipt. This rapid turnaround is a key differentiator, providing peace of mind and actionable information far faster than waiting for a vet appointment might allow.

Accessibility is another cornerstone of the strategy. With individual testing kits starting at $125 and a comprehensive 'Complete Health Kit' priced at $249, the company is positioning proactive screening as an affordable alternative to the potentially catastrophic costs of emergency care. This aligns with a powerful trend seen at SuperZoo 2026, where consumer demand for greater visibility into their pets' health and daily routines was a dominant theme. Petwealth is betting that by lowering the barriers of cost, convenience, and complexity, it can transform passive pet owners into proactive health managers.

Building a Connected Health Ecosystem

Perhaps the most critical component of Petwealth’s strategy is its refusal to operate in a vacuum. A common pitfall for direct-to-consumer health companies is leaving users with complex data they are unequipped to interpret. Petwealth preemptively solves this by building an integrated support network, true to its mantra: “Designed with vets. Trusted by vets. Built for pet parents.”

Through a strategic partnership with the telehealth service Pawp, Petwealth becomes its preferred diagnostic partner. This integration means that every Petwealth user has 24/7 on-demand access to Pawp’s licensed veterinary professionals via text or video. When a test result comes in, a pet parent can immediately connect with a vet to understand the findings, ask questions, and discuss appropriate next steps. This symbiotic relationship bridges the crucial gap between at-home data collection and professional medical guidance, effectively embedding a veterinarian into the digital experience.

“Petwealth partners with pet parents and vets to provide faster diagnostics and better health for our pets,” noted Dr. Amy Attas, a prominent NYC veterinarian and an advisor to the company. This endorsement from established professionals is vital for building trust.

Beyond telehealth, Petwealth is aggressively expanding its physical footprint through an exclusive partnership with Kennel Connection, a leading software provider for over 5,500 pet care businesses across the country. This move embeds Petwealth's screening tools directly into the daily operations of groomers, daycares, and boarding facilities. For these businesses, it offers a new revenue stream and a powerful biosecurity tool to prevent outbreaks of contagious illnesses like Bordetella or canine influenza. For Petwealth, it creates an invaluable distribution channel, meeting pet parents in trusted environments where they already spend time and money.

Jeff Brodsly, CEO of Kennel Connection, highlighted the strategic fit, stating, “Petwealth’s diagnostic technology represents the kind of forward-thinking solution our industry needs, and we’re proud to work together to bring this advancement to our clients and the pet parents they serve.”

The Technology Driving the Shift

Underpinning Petwealth's entire platform is a commitment to clinical-grade science. The company utilizes Polymerase Chain Reaction (PCR) testing, the same gold-standard molecular technology widely used in human medicine. Unlike visual inspections or less sensitive rapid tests, PCR diagnostics can detect the specific DNA of pathogens like Giardia or Salmonella with high accuracy, often at very low levels before an animal shows any symptoms.

This raw laboratory data is then processed through the company's proprietary platform. Using AI, it generates a “Health Score Data™” and translates complex biomarker information into clear, actionable reports. This crucial step demystifies the science for the average consumer, transforming a list of pathogens into a straightforward assessment of their pet’s current health status.

In an age of data sensitivity, the company also appears to be taking privacy seriously. Its policies state that personal information is not sold, and health data is shared with partners like Pawp only to facilitate the core service of providing care. By retaining results for at least seven years, the platform also enables longitudinal health tracking, allowing pet parents and their vets to monitor trends over time, creating a dynamic health profile for each animal.

Remapping the Pet Care Economy

With $1.7 million in pre-seed funding and a clear go-to-market strategy, Petwealth is positioning itself as a key disruptor in a U.S. pet care market valued at over $200 billion. Its model directly addresses several pain points in the current system: an overtaxed veterinary industry struggling with staffing shortages, long wait times for appointments, and the rising cost of care that often forces families into difficult financial decisions.

By decentralizing the initial diagnostic process, Petwealth empowers pet parents with information, turning the subsequent visit to a primary veterinarian into a more focused and productive conversation. Instead of arriving with vague concerns, a pet parent can arrive with a detailed report, enabling the veterinarian to move more quickly toward a targeted treatment plan. This creates a more efficient and effective system for all involved, distributing the load from a centralized clinic model to a network of empowered consumers and on-demand professionals.

This evolution represents a fundamental change in how health information is generated, accessed, and acted upon. By placing clinical-grade tools in the hands of consumers and backing them with a robust support network, Petwealth is not just selling test kits; it is building the infrastructure for a more resilient, responsive, and decentralized future for pet health.